China MOA Announcement No. 871 (January 3, 2025) — 6 New Veterinary Drug Approvals
中华人民共和国农业农村部公告 第 871 号 (MOA Announcement No. 871), issued 2025-01-03, published on the MOA official information portal on 2025-01-06.
Core Provision
Per the 《兽药管理条例》 (Regulations on Veterinary Drug Administration) and 《兽药注册办法》 (Measures for the Registration of Veterinary Drugs), the Ministry reviewed and approved 6 veterinary drug products as new veterinary drugs, applied by 20 organizations, and issued 《新兽药注册证书》 (New Veterinary Drug Registration Certificates), with published product quality standards, manufacturing process specifications, package inserts and labels, effective from the publication date.
The 6 New Veterinary Drugs
| # | New veterinary drug | 研制单位 (Developers) | Class | New Veterinary Drug Certificate No. | Monitoring period | Notes |
|---|---|---|---|---|---|---|
| 1 | 头孢维星钠 (Cefovecin Sodium) | 齐鲁晟华制药有限公司、广东温氏大华农生物科技有限公司动物保健品厂、内蒙古联邦动保药品有限公司、天津市中升挑战生物科技有限公司、重庆医药高等专科学校、齐鲁动物保健品有限公司 | 二类 (Class 2) | （2025）新兽药证字 1 号 | 4 年 (4 years) | / |
| 2 | 注射用头孢维星钠 (Cefovecin Sodium for Injection) | 齐鲁动物保健品有限公司、广东温氏大华农生物科技有限公司动物保健品厂、内蒙古联邦动保药品有限公司、天津市中升挑战生物科技有限公司、重庆医药高等专科学校 | 二类 (Class 2) | （2025）新兽药证字 2 号 | 4 年 | / |
| 3 | 牛支原体灭活疫苗（CO 株） (Bovine Mycoplasma Inactivated Vaccine, CO strain) | 北京生泰尔科技股份有限公司、北京华夏兴洋生物科技有限公司、生泰尔（内蒙古）科技有限公司 | 二类 (Class 2) | （2025）新兽药证字 3 号 | 4 年 | / |
| 4 | 蒿板青颗粒 (Artemisia–Isatis Granules) | 中国农业大学、烟台海研制药有限公司、潍坊华英生物科技有限公司、山东德州神牛药业有限公司 | 三类 (Class 3) | （2025）新兽药证字 4 号 | 3 年 | / |
| 5 | 鸡新城疫、禽流感（H9 亚型）、禽腺病毒（I 群，4 型）三联灭活疫苗（N7a 株+HF 株+Fiber-2 蛋白） (Newcastle Disease + Avian Influenza H9 + Fowl Adenovirus Group I Serotype 4 Trivalent Inactivated Vaccine) | 普莱柯生物工程股份有限公司、洛阳惠中生物技术有限公司 | 三类 (Class 3) | （2025）新兽药证字 5 号 | 3 年 | / |
| 6 | 米氮平软膏 (Mirtazapine Ointment) | 南京朗博特动物药业有限公司、江苏朗博特动物药品有限公司、湖北回盛生物科技有限公司、河北远征药业有限公司、南京乐宠乐家生物制药有限公司 | 五类 (Class 5) | （2025）新兽药证字 6 号 | 3 年 | 列入兽用处方药目录 (Listed in the Veterinary Prescription Drug Catalog) |
Veterinary Drugs with Pet-Animal Relevance
Among the 6, the following have direct or indirect pet-animal use relevance:
- 米氮平软膏 (Mirtazapine Ointment, #6) — an appetite stimulant and anti-nausea topical widely used in companion animal practice (dogs and cats) for management of anorexia and weight loss. The MOA registration path is Class 5 (generic / off-patent), monitoring period 3 years, and explicitly listed in the Veterinary Prescription Drug Catalog (兽用处方药目录), confirming prescription-only dispensing for veterinary use.
Source
pdf-raw/cn-approvals/moa-announcement-871-20250106.html (MOA 农业农村信息网 http://www.agri.cn/zx/hxgg/202501/t20250106_8703900.htm, downloaded 2026-07-21, 102 KB). All 8 verified claims substring-matched against the announcement text including the developer company names, certificate numbers, drug classes and monitoring periods.
For related pet-veterinary-drug announcements in 2026, see companion topics cn_moa_ann1022_new_veterinary_drugs_pet (May 2026, fluralaner drops) and cn_moa_ann1026_new_veterinary_drugs_pet (June 2026, canine distemper antiserum + itraconazole ointment).